Nomogram predicting the risk of recurrence after curative‐intent resection of primary non‐metastatic gastrointestinal neuroendocrine tumors: An analysis of the U.S. Neuroendocrine Tumor Study Group

The risk of recurrence after resection of non‐metastatic gastro‐entero‐pancreatic neuroendocrine tumors (GEP‐NET) is poorly defined. We developed/validated a nomogram to predict risk of recurrence after curative‐intent resection.

[1]  A. Dasari,et al.  Clinical, pathological, and demographic factors associated with development of recurrences after surgical resection in elderly patients with neuroendocrine tumors , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

[2]  J. Park,et al.  Predictive Factors for Lymph Node Metastasis and Prognostic Factors for Survival in Rectal Neuroendocrine Tumors , 2017, Journal of Gastrointestinal Surgery.

[3]  J. Wisnivesky,et al.  Lymph Node Metastasis in the Prognosis of Gastroenteropancreatic Neuroendocrine Tumors , 2017, Pancreas.

[4]  Shouhao Zhou,et al.  Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States , 2017, JAMA oncology.

[5]  Minhu Chen,et al.  Nomogram individually predicts the overall survival of patients with gastroenteropancreatic neuroendocrine neoplasms , 2017, British Journal of Cancer.

[6]  R. Hruban,et al.  Pancreatic Neuroendocrine Tumors: Update on the New World Health Organization Classification , 2017, AJSP: Reviews and Reports.

[7]  Seung‐Mo Hong,et al.  Recent updates on grading and classification of neuroendocrine tumors. , 2017, Annals of diagnostic pathology.

[8]  G. Spolverato,et al.  Neuroendocrine Liver Metastasis: Prognostic Implications of Primary Tumor Site on Patients Undergoing Curative Intent Liver Surgery , 2017, Journal of Gastrointestinal Surgery.

[9]  E. Nakakura,et al.  The Surgical Management of Small Bowel Neuroendocrine Tumors: Consensus Guidelines of the North American Neuroendocrine Tumor Society , 2017, Pancreas.

[10]  M. Grzybowski,et al.  Novel nomogram combining depth of invasion and size can accurately predict the risk for regional nodal metastases for appendiceal neuroendocrine tumors (A‐NET) , 2017, Journal of surgical oncology.

[11]  P. Zhao,et al.  Predictive value of preoperative peripheral blood neutrophil/lymphocyte ratio for lymph node metastasis in patients of resectable pancreatic neuroendocrine tumors: a nomogram-based study , 2017, World Journal of Surgical Oncology.

[12]  J. Wisnivesky,et al.  Improving survival prognostication of gastroenteropancreatic neuroendocrine neoplasms: Revised staging criteria. , 2017, European journal of cancer.

[13]  P. Ruszniewski,et al.  Gastroenteropancreatic Well-Differentiated Grade 3 Neuroendocrine Tumors: Review and Position Statement. , 2016, The oncologist.

[14]  C. Mosquera,et al.  Localized high-grade gastroenteropancreatic neuroendocrine tumors: Defining prognostic and therapeutic factors for a disease of increasing clinical significance. , 2016, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[15]  S. Maithel,et al.  Symptomatic presentation as a predictor of recurrence in gastroenteropancreatic neuroendocrine tumors: A single institution experience over 15 years , 2016, Journal of surgical oncology.

[16]  Chang-ming Huang,et al.  A novel predictive model based on preoperative blood neutrophil-to-lymphocyte ratio for survival prognosis in patients with gastric neuroendocrine neoplasms , 2016, Oncotarget.

[17]  S. Asa,et al.  Diagnosis and management of gastrointestinal neuroendocrine tumors: An evidence-based Canadian consensus. , 2016, Cancer treatment reviews.

[18]  Quanbo Zhou,et al.  A retrospective cohort study of pancreatic neuroendocrine tumors at single institution over 15 years: New proposal for low- and high-grade groups, validation of a nomogram for prognosis, and novel follow-up strategy for liver metastases. , 2016, International journal of surgery.

[19]  Xubao Liu,et al.  TNM Staging of Pancreatic Neuroendocrine Tumors: An Observational Analysis and Comparison by Both AJCC and ENETS Systems From 1 Single Institution: Erratum , 2016, Medicine.

[20]  H. Sorbye,et al.  ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas , 2016, Neuroendocrinology.

[21]  K. Søreide,et al.  Epidemiology and classification of gastroenteropancreatic neuroendocrine neoplasms using current coding criteria , 2015, The British journal of surgery.

[22]  A. Lamarca,et al.  Prognostic factors for disease relapse in patients with neuroendocrine tumours who underwent curative surgery. , 2015, Surgical oncology.

[23]  M. Papotti,et al.  Survival prognostic factors of gastro-enteric-pancreatic neuroendocrine tumors after primary tumor resection in a single tertiary center: Comparison of gastro-enteric and pancreatic locations. , 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[24]  W. Lou,et al.  The value of serum chromogranin A as a predictor of tumor burden, therapeutic response, and nomogram-based survival in well-moderate nonfunctional pancreatic neuroendocrine tumors with liver metastases , 2015, European journal of gastroenterology & hepatology.

[25]  R. Saskin,et al.  Exploring the rising incidence of neuroendocrine tumors: A population‐based analysis of epidemiology, metastatic presentation, and outcomes , 2015, Cancer.

[26]  R. Moll,et al.  Well-Differentiated Neuroendocrine Neoplasia: Relapse-Free Survival and Predictors of Recurrence after Curative Intended Resections , 2014, Digestion.

[27]  A. Faggiano,et al.  Incidence of gastroenteropancreatic neuroendocrine tumours: a systematic review of the literature. , 2014, Endocrine-related cancer.

[28]  Toby C. Cornish,et al.  A Single Institution's 26-Year Experience With Nonfunctional Pancreatic Neuroendocrine Tumors: A Validation of Current Staging Systems and a New Prognostic Nomogram , 2014, Annals of surgery.

[29]  D. Metz,et al.  Consensus guidelines for the management and treatment of neuroendocrine tumors. , 2013, Pancreas.

[30]  Xihong Lin,et al.  Clinical presentation, recurrence, and survival in patients with neuroendocrine tumors: results from a prospective institutional database. , 2013, Endocrine-related cancer.

[31]  Y. Bang,et al.  Clinical Course of Neuroendocrine Tumors With Different Origins (the Pancreas, Gastrointestinal Tract, and Lung) , 2012, American journal of clinical oncology.

[32]  L. Kvols,et al.  Relapse-Free Survival in Patients With Nonmetastatic, Surgically Resected Pancreatic Neuroendocrine Tumors: An Analysis of the AJCC and ENETS Staging Classifications , 2012, Annals of surgery.

[33]  A. Scarpa,et al.  Malignant pancreatic neuroendocrine tumour: lymph node ratio and Ki67 are predictors of recurrence after curative resections. , 2012, European journal of cancer.

[34]  A. Scarpa,et al.  TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study. , 2012, Journal of the National Cancer Institute.

[35]  Qin Huang,et al.  Tumor Size and Depth Predict Rate of Lymph Node Metastasis in Colon Carcinoids and Can Be Used to Select Patients for Endoscopic Resection , 2012, Journal of Gastrointestinal Surgery.

[36]  T. Ohtsuka,et al.  Analysis of lymph node metastasis in pancreatic neuroendocrine tumors (PNETs) based on the tumor size and hormonal production , 2012, Journal of Gastroenterology.

[37]  Stef van Buuren,et al.  MICE: Multivariate Imputation by Chained Equations in R , 2011 .

[38]  Qin Huang,et al.  Tumor Size and Depth Predict Rate of Lymph Node Metastasis and Utilization of Lymph Node Sampling in Surgically Managed Gastric Carcinoids , 2011, Annals of Surgical Oncology.

[39]  I. Modlin,et al.  A Nomogram to Assess Small-Intestinal Neuroendocrine Tumor (‘Carcinoid’) Survival , 2010, Neuroendocrinology.

[40]  William Mantovani,et al.  Pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients , 2010, Modern Pathology.

[41]  Shahrokh F. Shariat,et al.  Comparison of Nomograms With Other Methods for Predicting Outcomes in Prostate Cancer: A Critical Analysis of the Literature , 2008, Clinical Cancer Research.

[42]  Manal M. Hassan,et al.  One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  L. Sobin,et al.  The Staging of Cancer: A Retrospective and Prospective Appraisal , 2008, CA: a cancer journal for clinicians.

[44]  J. Tyson,et al.  Clinical research methodology I: introduction to randomized trials. , 2008, Journal of the American College of Surgeons.

[45]  A. Scarpa,et al.  TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system , 2007, Virchows Archiv.

[46]  A. Scarpa,et al.  TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system , 2006, Virchows Archiv : an international journal of pathology.

[47]  G. Pelosi,et al.  Endocrine tumors of the pancreas: Ki-67 immunoreactivity on paraffin sections is an independent predictor for malignancy: a comparative study with proliferating-cell nuclear antigen and progesterone receptor protein immunostaining, mitotic index, and other clinicopathologic variables. , 1996, Human pathology.

[48]  Eva Segelov,et al.  The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Midgut Neuroendocrine Tumors , 2017, Pancreas.

[49]  J. Berlin,et al.  Neuroendocrine tumors, version 1.2015. , 2015, Journal of the National Comprehensive Cancer Network : JNCCN.

[50]  F. Bosman,et al.  WHO Classification of Tumours of the Digestive System , 2010 .

[51]  E. Somers.  International Agency for Research on Cancer. , 1985, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[52]  O. Beahrs.  The American Joint Committee on Cancer. , 1984, Bulletin of the American College of Surgeons.